X0609 4 2026-05-21 0001281895 ROCKET PHARMACEUTICALS, INC. RCKT 0001725922 Shah Gaurav false C/O ROCKET PHARMACEUTICALS, INC. 9 CEDARBROOK DRIVE CRANBURY NJ 08512 true CEO false Common Stock 2026-05-21 4 M 0 76490 1.691 A 1117408 D Common Stock 2026-05-21 4 S 0 55684 3.086 D 1061724 D Common Stock 207897 I By Spouse Common Stock 198341 I By Gaurav D. Shah Irrevocable Trust Stock Option (Right to Buy) 1.691 2026-05-21 4 M 0 76490 1.691 D 2027-04-12 Common Stock 76490 0 D Holdings include Restricted Stock Units that convert to common stock on a one-for-one basis. Represents shares received upon exercise of a Stock Option in advance of the expiration of such Stock Option. Represents shares sold by the Reporting Person in order to pay the exercise price of a Stock Option and to cover certain taxes in connection with the exercise of the Stock Option. Represents a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $3.08 to $3.105. The Reporting Person has provided the issuer and will provide any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. This option represents a right to purchase a total of 76,490 shares of the Issuer's Common Stock, one-third of which became fully vested and exercisable on April 12, 2018, with the remaining two-thirds vesting in equal quarterly installments over the following two years. /s/ Martin Wilson, as attorney-in-fact for Gaurav Shah 2026-05-26